Changes in aac(6′)-Ib-cr prevalence and fluoroquinolone resistance in nosocomial isolates of escherichia coli collected from 1991 through 2005

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 3, 2009, Pages 1268-1270

  Warburg, Gabriela ^a   Korem, Maya ^a   Robicsek, Ari ^b   Engelstein, Dalia ^a   Moses, Allon E ^a   Block, Colin ^a   Strahilevitz, Jacob ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BETA LACTAMASE; CEFTAZIDIME; CIPROFLOXACIN; PROTEIN AAC; PROTEIN QNR; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; ESCHERICHIA COLI; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BETA-LACTAMASES; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FLUOROQUINOLONES; GENES, BACTERIAL; GUIDELINES AS TOPIC; HUMANS; MICROBIAL SENSITIVITY TESTS; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 62949143186     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01300-08     Document Type: Article

References (18)

1. Abravaya, K., J. J, Carrino, S. Muldoon, and H. H. Lee. 1995. Detection of point mutations with a modified ligase chain reaction (Gap-LCR). Nucleic Acids Res. 23:675-682.
2. Ambrozic Avgustin, J., R. Keber, K, Zerjavic, T. Orazem, and M, Grabnar. 2007. Emergence of the quinolone resistance-mediating gene aac(6')-ib-cr in extended-spectrum-β-lactamase-producing Klebsiella isolates collected in Slovenia between 2000 and 2005. Antimicrob. Agents Chemother. 51:4171- 4173.
3. Clinical and Laboratory Standards Institute. 2007. Performance standards for antimicrobial susceptibility testing; 15th informational supplement. M100-S17. Clinical and Laboratory Standards Institute. Wayne. PA.
4. Coque, T. M., A, Novais, A. Carattoli, L. Poirel, J. Pitout, L. Peixe, F. Baquero, R. Canton, and P. Nordmann. 2008. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerg. Infect. Dis. 14:195-200.
5. blaKPC in the United States. Antimicrob. Agents Chemother. 52:2680-2682.
6. Hoffmann, H., E. Sturenburg, J. Heesemann, and A. Roggenkamp. 2006. Prevalence of extended-spectrum beta-lactamases in isolates of the Enterobacter cloacae complex from German hospitals. Clin. Microbiol. Infect. 12: 322-330.
7. Jacoby, G. A., K. E. Walsh, D. M. Mills, V. J. Walker, H. Oh, A. Robicsek, and D. C. Hooper. 2006. qnrB, another plasmid-mediated gene for quinolone resistance. Antimicrob. Agents Chemother. 50:1178-1182.
8. Martinez-Martinez, L., A. Pascual, and G. A. Jacoby. 1998. Quinolone resistance from a transferable plasmid. Lancet 351:797.
9. Monstein, H. J., A. Ostholm-Balkhed, M. V. Nilsson, M. Nilsson, K. Dornbusch, and L. E. Nilsson. 2007. Multiplex PCR amplification assay for the detection of blaSHV, blaTEM and blaCTX-M genes in Enterobacteriaceae. APM1S 115:1400-1408.
10. Park, C. H., A. Robicsek, G, A. Jacoby, D. Sahm, and D. C. Hooper. 2006. Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin- moditying enzyme. Antimicrob. Agents Chemother. 50:3953-3955.
11. Pitout, J. D., N. Hamilton, D. L. Church, P. Nordmann, and L. Poirel. 2007. Development and clinical validation of a molecular diagnostic assay to detect CTX-M-type beta-lactamases in Enterobacteriaceae. Clin. Microbiol. Infect. 13:291-297.
12. Pitout, J. D. D., Y. Wei, D. L. Church, and D. B. Gregson. 2008. Surveillance for plasmid-mediated quinolone resistance determinants in Enterobacteriaceae within the Calgary Health Region, Canada: the emergence of aac(6')- Ib-cr. J. Antimicrob. Chemother. 61:999-1002.
13. Ribot, E. M., M. A. Fair, R. Gautom, D. N. Cameron, S. B. Hunter, B. Swaminathan, and T. J. Barrett. 2006. Standardization of pulsed-field gel electrophoresis protocols for the sub typing of Escherichia coli OL57:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog. Dis. 3:59-67.
14. Robicsek, A., G. A. Jacoby, and D. C. Hooper. 2006. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect. Dis. 6:629- 640.
15. Robicsek, A., J. Strahilevitz, G. A. Jacoby, M. Macielag, D. Abbanat, P. C. Hye, K. Bush, and D. C. Hooper. 2006. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat. Med. 12:83.
16. Robicsek, A., J, Strahilevitz, D. F. Sahm, G. A, Jacoby, and D, C. Hooper. 2006. qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob. Agents Chemother. 50:2872-2874.
17. Strahilevitz, J., D. Engelstein, A. Adler, V. Temper, A. E. Moses, C. Block, and A. Robicsek. 2007. Changes in qnr prevalence and fluoroquinolone resistance in clinical isolates of Klebsiella pneumoniae and Enterobacter spp. collected from 1990 to 2005. Antimicrob. Agents Chemother. 51:3001-3003.
18. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D, H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.